US President Trump signs executive order to accelerate psychedelic drug research
US President Donald Trump signed an executive order on April 19, 2026, aimed at easing restrictions on federal research into psychedelic drugs such as psilocybin and LSD.The order is intended to reduce bureaucratic hurdles and facilitate faster studies by federal agencies.It directs improved data sharing between the Food and Drug Administration (FDA) and the Department of Veterans Affairs and aims to expedite the rescheduling process for psychedelic drugs if they receive FDA approval.Currently, these substances are classified as having high abuse potential, limiting their medical research and use.The order does not immediately change the legal status of these drugs or... [Continue Reading]
360LiveNews | 19 Apr 2026 09:31 LONDON
